Navigation Links
WellTek/MedX Group Completes Major Reorganization
Date:11/11/2009

ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- WellTek/MedX Group, health, fitness and wellness companies, today announced that it has completed a major corporate reorganization to facilitate becoming an SEC reporting company.

On November 11, 2009, MedX Systems, Inc. merged into a wholly owned subsidiary of an SEC reporting public company, previously named Pharmacity Corporation, and subsequently changed its name to WellTek Incorporated. As a result of the merger, there are 85,783,828 shares of common stock outstanding, including approximately 70,000,000 shares issued in the merger. In addition, there are outstanding options and warrants exercisable into an aggregate of 8,660,411 shares of WellTek Incorporated.

"As a consequence of this transaction, we now have a viable, trading market for our common stock. Moreover, management is now free to focus exclusively on executing our growth strategies and building long term value for our trusted shareholders," stated Randy Lubinsky, Chairman and CEO.

For more detailed information, please refer to the Form 8-K to be filed with the U.S. Securities and Exchange Commission. To view, please visit www.sec.gov.

About WellTek Incorporated

WellTek is a global health, fitness and wellness company that provides solutions to help address some of the world's most pressing and costly health challenges--obesity and chronic neck and back pain. The Company's subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. The Comp
'/>"/>

SOURCE WellTek Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hill-Rom and Encompass Group Form Joint Venture
2. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
3. EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Companys Robust Practice Management Software
4. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
5. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
6. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
9. Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiarys Stock to Investors
10. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
11. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , January 23, 2015 Heptares Therapeutics, ... delighted to announce that the Malcolm Campbell Memorial ... (Vice President of Chemistry), Fiona Marshall (Chief ... Executive Officer and co-founder) for the seminal contributions to GPCR ...
(Date:1/22/2015)... 22, 2015  BiOptix is pleased to announce the appointment ... of Chemistry and Biochemistry. Scott joins the company after previous ... Amgen throughout the course of his nearly 20 year ... is a nationally recognized thought leader in the biosensor ...
(Date:1/22/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a ... cardiovascular disease and overall health is pleased to provide you ... its outlook for 2015 from the CEO, Mr. Eugene ... would like to take this opportunity to share with you ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... BOSTON, Dec. 29, 2011  Solos Endoscopy, Inc. (OTCPK: SNDY) ... continued growth in 2012 through the development and sales ... treatment and management of medical conditions. In 2011, Solos ... approximately $300,000 in debt for the Company. The signed ...
... Dec. 29, 2011 Janssen Research & Development, LLC (JRD) ... Application (sNDA) to the U.S. Food and Drug Administration (FDA) ... an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular ... The filing is supported by data from the pivotal Phase ...
Cached Medicine Technology:Solos Endoscopy, Inc. is Primed for Growth in 2012 2Solos Endoscopy, Inc. is Primed for Growth in 2012 3Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 2Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 3Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 4Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 5Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 6Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 7Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 8Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 9Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 10Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 11
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... from this to a human ,fountain of youth, however , , ... been able to temporarily return old skin cells to their ... , "This gene gets more and more active with age," ... dermatology at Stanford University. "It doesn,t exist to make ...
... PHILADELPHIA - A study led by a University of ... is challenging the widely held belief that mice are the ... , The paper, published in the Proceedings of the Royal ... just mice, are the four species that account for major ...
... Families, FRESNO, Calif., Nov. 29 Several locals ... T.,Perea for mayor of Fresno, and Supervisors Susan Anderson ... The endorsements were made after a One Voice ... 1000, and United Healthcare Workers-West,voted on which candidates were ...
... Necessary to Protect All ... Consumers, ... delayed its decision on adopting a new rule and,rating system for over-the-counter ... Karl,Gruber, a surgical pathologist and expert in sun protection., The new ...
... so many problems in our health care delivery,system and ... are having problems getting care as well as paying ... Health & Science University,family physician. The study, "Insurance Plus ... Health Care Access for Low Income,Families," recently was published ...
... 2007)Sometimes healthy cells commit suicide. In the 1970s, scientists ... apoptosis plays a key role in development, and the ... work. As apoptotic cells degrade, they display standard characteristics, ... , Now, Harvard Medical School researchers have uncovered a ...
Cached Medicine News:Health News:Gene Tweak Reverses Aging in Mouse Skin Cells 2Health News:University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic 2Health News:SEIU Endorses Anderson, Perea, and Perea in Fresno 2Health News:FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, 'Enough Is Enough' 2Health News:New study shows low-income families face 3 barriers to health care 2Health News:New study shows low-income families face 3 barriers to health care 3Health News:Homeless cells find temporary lodging -- and their demise 2Health News:Homeless cells find temporary lodging -- and their demise 3
... A new Transnasal Lacrimal Stent has been introduced ... Becker, M.D., the Transnasal Lacrimal Stent addressed the ... other forms of endoscopic DCR. Brought in to ... large diameter. Because there is no need to ...
... With the OrthoPilot, physicians now have a ... interventions. , ,The only platform you ... a complete, cost-effective system requiring little space. ... new applications make OrthoPilot a strong and ...
... Field Analyzer II-i series is a wheelchair ... patient's visual field. ,By using SITA, the ... reduced by up to 70%. ,A patented ... design to increase patient comfort while testing ...
... is an innovative device designed to be ... with abdominal aortic aneurysms (AAA). It is ... with an outer self-expanding Nitinol support structure ... durability. The function of the endoprosthesis is ...
Medicine Products: